Show simple item record

dc.contributor.authorLin, Lih-Ling
dc.contributor.authorWartmann, Markus
dc.contributor.authorLin, Alice Y.
dc.contributor.authorKnop, John L.
dc.contributor.authorSeth, Alpna
dc.contributor.authorDavis, Roger J.
dc.date2022-08-11T08:09:01.000
dc.date.accessioned2022-08-23T16:15:29Z
dc.date.available2022-08-23T16:15:29Z
dc.date.issued1993-01-29
dc.date.submitted2008-11-05
dc.identifier.citationCell. 1993 Jan 29;72(2):269-78.
dc.identifier.issn0092-8674 (Print)
dc.identifier.pmid8381049
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34099
dc.description.abstractTreatment of cells with agents that stimulate the release of arachidonic acid causes increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). Here we report that cPLA2 is a substrate for mitogen-activated protein (MAP) kinase. Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The site of cPLA2 phosphorylation by MAP kinase, Ser-505, is identical to the major site of cPLA2 phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala resulted in a mutant cPLA2 that is not a substrate for MAP kinase and causes little or no enhanced agonist-stimulated arachidonate release from intact cells. Taken together, these data indicate that MAP kinase mediates, at least in part, the agonist-induced activation of cPLA2.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8381049&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/0092-8674(93)90666-E
dc.subjectAmino Acid Sequence; Animals; CHO Cells; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cricetinae; Cytosol; Enzyme Activation; Kinetics; Models, Biological; Mutagenesis, Site-Directed; Peptide Mapping; Phospholipases A; Phospholipases A2; Phosphopeptides; Phosphorylation; Protein Kinase C; Protein Kinases; Receptors, Platelet-Derived Growth Factor; Recombinant Proteins; Serine; Tetradecanoylphorbol Acetate; Transfection
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titlecPLA2 is phosphorylated and activated by MAP kinase
dc.typeJournal Article
dc.source.journaltitleCell
dc.source.volume72
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/763
dc.identifier.contextkey661872
html.description.abstract<p>Treatment of cells with agents that stimulate the release of arachidonic acid causes increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). Here we report that cPLA2 is a substrate for mitogen-activated protein (MAP) kinase. Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The site of cPLA2 phosphorylation by MAP kinase, Ser-505, is identical to the major site of cPLA2 phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala resulted in a mutant cPLA2 that is not a substrate for MAP kinase and causes little or no enhanced agonist-stimulated arachidonate release from intact cells. Taken together, these data indicate that MAP kinase mediates, at least in part, the agonist-induced activation of cPLA2.</p>
dc.identifier.submissionpathgsbs_sp/763
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentHoward Hughes Medical Institute Department of Biochemistry and Molecular Biology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages269-78


This item appears in the following Collection(s)

Show simple item record